LNPEP c.225G>A ;(p.K75=)

Variant ID: 5-96315047-G-A

NM_005575.2(LNPEP):c.225G>A;(p.K75=)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.

Molecular Oncology
Feiersinger, Gertrud E GE; Trattnig, Kristina K; Leitner, Peter D PD; Guggenberger, Fabian F; Oberhuber, Alexander A; Peer, Sarah S; Hermann, Martin M; Skvortsova, Ira I; Vrbkova, Jana J; Bouchal, Jan J; Culig, Zoran Z; Santer, Frédéric R FR
Publication Date: 2018-04

Variant appearance in text: LNPEP: 225G>A; K75K
PubMed Link: 29465803
Variant Present in the following documents:
  • MOL2-12-561-s006.xlsx, sheet 3
View BVdb publication page